Did you know that the Latin American region has the third largest economy in the world by GDP with a healthcare expenditure comparable to that of China or India?1 Made up of dozens of countries, Latin America is home to 500 million residents.
The increased focus on healthcare in Latin America is primarily driven by rising populations, a growing middle class with increasing disposable income, and high demand for quality healthcare products. And, it's predicted that markets in the region will continue to grow. For example, the total pharmaceutical market in Latin America, excluding Venezuela, is estimated to grow one-and-a-half times faster than developed markets over the coming years, reaching $50 billion by 2018.2
Abbott Medicines in Latin America
Abbott has a rich history in Latin America, specifically through its branded pharmaceuticals business. Our significant manufacturing, innovation and development presence throughout the region has allowed us to bring meaningful innovation to emerging markets to help people live healthier, fuller lives. Click to learn more.
Fast Facts: Did you know...
1. Emergo: The medical devices market in Latin America
2. Business Monitor International, Q1 2017 Outlook
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.